PDAC and LUAD tumors propagated in each organ had a similar tumor burden and disease histopathology, as well as anti-proliferative (Ki67) and on-target drug responses (pRb) to T/P treatment (Extended Data Fig. 1a,b). This evidence concerns the gene MKI67 and neoplasm.